British brain imaging study to focus on LSD

Scientists at Imperial College London are trying to complete a brain imaging study to demystify the effects of the psychedelic drug LSD, and they are turning to crowdfunding to support the project.

David Nutt, DM, psychiatrist and professor of psychopharmacology, and colleagues are looking for an additional 25,000 pounds ($38,000) to complete their work, according to a Reuters report. The study would produce the first images of a brain on LSD and could increase understanding of how the drug could help treat afflictions such as alcoholism, depression and anxiety.

You can watch the researcher’s appeal for funding in this video, and learn more about the project from the Reuters report at the link below:

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.